Overview
Massimo Ganassi practices practicing medicine in London, United Kingdom.
Mr. Ganassi is highly rated in 1 condition, according to our data. His clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD) and Rhabdomyosarcoma.
He is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Massimo Ganassi
Is Massimo Ganassi a top-rated expert for Facioscapulohumeral Muscular Dystrophy (FSHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Massimo Ganassi is classified as an Advanced expert for Facioscapulohumeral Muscular Dystrophy (FSHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Massimo Ganassi participate in research or clinical trials?
Yes. Massimo Ganassi has published 22 articles and abstracts on conditions like Facioscapulohumeral Muscular Dystrophy (FSHD). You can view a list of Massimo Ganassi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Experienced
- RhabdomyosarcomaMr. Ganassi isExperienced. Learn about Rhabdomyosarcoma.